for Tardive Dyskinesia in Adults

HELP GAIN CONTROL OF Tardive Dyskinesia (TD) MOVEMENTS

>70%

of adults experienced a
reduction in td movements*

*In a 12-week clinical study, people taking AUSTEDO® (deutetrabenazine) tablets had at least a 10% reduction based on the total motor Abnormal Involuntary Movement
Scale (AIMS) score at Week 12.

AUSTEDO XR® can

reduce  td
movements in
some
as early as 2 weeks

AUSTEDO XR can be taken with

most mental health
medications

96%

of patients continued taking AUSTEDO XR without needing to reduce their dose due to side effects

AUSTEDO delivered consistent movement improvement and established safety results in a 3-year study.

AUSTEDO delivered
consistent movement improvement and established
safety results in a 3-year study.

This was an open-label study, which is a drug
trial in which all participants are
aware of the drug
being tested.

ask your healthcare

provider if austedo xr

is right for you

Once-daily AUSTEDO XR contains the same active ingredient as twice-daily AUSTEDO. Data on this page is based on twice-daily dosing.

Nearly 9 out of
10 people reported being satisfied with AUSTEDO XR

Based on a survey analysis from
131 people on AUSTEDO XR.

Nearly 9 out of 10 people are satisfied with AUSTEDO XR®
Learn more about how TD is diagnosed from this video.

Rebecca's partnership with her healthcare provider made it possible to diagnose her with TD and treat it with AUSTEDO

I didn't notice these things were related to a condition that was treatable. I just noticed I started having difficulty with simple tasks like cutting or buttoning, zippering, counting change.

Rebecca, living with TD

Individual results may vary.